Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors

Efficacy and safety of two different testosterone undecanoate formulations in hypogonadal men with metabolic syndrome

(2014) Antonio Aversa et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

The effect of androgens on lipids

(2013) Anne K. Monroe et al.   Current Opinion in Endocrinology Diabetes and Obesity

Adverse Effects of Testosterone Therapy in Adult Men: A Systematic Review and Meta-Analysis

(2010) M. Mercè Fernández-Balsells et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Cardiovascular Risk Factors and Morbidity in Long-Term Survivors of Testicular Cancer: A 20-Year Follow-Up Study

(2010) Hege S. Haugnes et al.   JOURNAL OF CLINICAL ONCOLOGY

Biology of insulin-like factor 3 in human reproduction

(2009) R. Ivell et al.   HUMAN REPRODUCTION UPDATE

European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part I

(2008) Susanne Krege et al.   EUROPEAN UROLOGY

Pretreatment Semen Parameters in Men With Cancer

(2008) Daniel H. Williams et al.   JOURNAL OF UROLOGY

Predicted cardiovascular mortality and reported cardiovascular morbidity in testicular cancer survivors

(2008) H. S. Haugnes et al.   Journal of Cancer Survivorship